Business Description
DaVita Inc
NAICS : 621492
SIC : 8092
ISIN : US23918K1088
Compare
Compare
Traded in other countries / regions
DVA.USATRL.GermanyDVA.MexicoDVAI34.Brazil0I7E.UK IPO Date
2018-01-18Description
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.06 | |||||
| Debt-to-Equity | 10.53 | |||||
| Debt-to-EBITDA | 4.79 | |||||
| Interest Coverage | 4.02 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.61 | |||||
| Beneish M-Score | -2.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EBITDA Growth Rate | 10.7 | |||||
| 3-Year EPS without NRI Growth Rate | 6.3 | |||||
| 3-Year FCF Growth Rate | 14.6 | |||||
| 3-Year Book Growth Rate | -1.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 15 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.75 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 5.08 | |||||
| Days Sales Outstanding | 61.4 | |||||
| Days Payable | 20.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 6.9 | |||||
| Shareholder Yield % | 8.73 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.47 | |||||
| Operating Margin % | 13.19 | |||||
| Net Margin % | 5.7 | |||||
| FCF Margin % | 12.28 | |||||
| ROE % | 71.88 | |||||
| ROA % | 4.09 | |||||
| ROIC % | 8.16 | |||||
| ROC (Joel Greenblatt) % | 25.95 | |||||
| ROCE % | 10.99 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.04 | |||||
| Forward PE Ratio | 14.53 | |||||
| PE Ratio without NRI | 17.07 | |||||
| Shiller PE Ratio | 24.73 | |||||
| Price-to-Owner-Earnings | 12.13 | |||||
| PEG Ratio | 1.15 | |||||
| PS Ratio | 1.02 | |||||
| PB Ratio | 11.23 | |||||
| Price-to-Free-Cash-Flow | 8.35 | |||||
| Price-to-Operating-Cash-Flow | 6.05 | |||||
| EV-to-EBIT | 14.21 | |||||
| EV-to-EBITDA | 9.64 | |||||
| EV-to-Revenue | 1.84 | |||||
| EV-to-FCF | 15.01 | |||||
| Price-to-Projected-FCF | 0.69 | |||||
| Price-to-DCF (Earnings Based) | 0.93 | |||||
| Price-to-DCF (FCF Based) | 0.4 | |||||
| Price-to-Median-PS-Value | 0.94 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.16 | |||||
| Earnings Yield (Greenblatt) % | 7.04 | |||||
| FCF Yield % | 12.79 | |||||
| Forward Rate of Return (Yacktman) % | 22.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DaVita Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12,140.147 | ||
| EPS (TTM) ($) | 7.4 | ||
| Beta | 0.2 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 123.22 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 123.22 - 123.22 | ||
| Shares Outstanding (Mil) | 87.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DaVita Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DaVita Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DaVita Inc Frequently Asked Questions
What is DaVita Inc(LTS:0I7E)'s stock price today?
The current price of LTS:0I7E is $123.22. The 52 week high of LTS:0I7E is $123.22 and 52 week low is $123.22.
When is next earnings date of DaVita Inc(LTS:0I7E)?
The next earnings date of DaVita Inc(LTS:0I7E) is 2024-05-02.
Does DaVita Inc(LTS:0I7E) pay dividends? If so, how much?
DaVita Inc(LTS:0I7E) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers